
|Articles|August 10, 2009
Cardiocore Selected as Preferred Provider
Advertisement
Cardiocore, a centralized cardiac testing lab, announced its preferred provider status with a top 10 pharmaceutical company. Cardiocore was awarded cardiac safety service contracts in multi-year studies including a Thorough QT study and retrospective paper ECG analyses.
This is the company's second such announcement in the past three months. It had previously
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Designing Feasible Protocols with Real-World Data
3
ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation
4
FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains
5






.png)



.png)



.png)
.png)
